| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.068 | 0.7 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.067 | 0.7 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.053 | 0.7 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |